4C Solutions That Preserve the Native Mitral Valve Technology and Clinical Trial Update

Tuesday, February 28, 2023

11:26 AM – 11:34 AM ET

Speaker(s)

Jeffrey W. Chambers, MD, FSCAI, FACC (he/him/his)

Director of the Cardiac catheterization Lab
Metropolitian Heart and Vascular Institute
Minneapolis, Minnesota, United States

Disclosure(s): Cardiovascular Systems Inc: Employee (Ongoing), Salary (Ongoing), Shareholder (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Disclosure(s):

Jeffrey W. Chambers, MD, FSCAI, FACC: Cardiovascular Systems Inc: Employee (Ongoing), Salary (Ongoing), Shareholder (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)